Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Long-Term Deferred Tax (2021)

Volitionrx (VNRX) has disclosed Long-Term Deferred Tax for 4 consecutive years, with $37.1 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Long-Term Deferred Tax rose 20.31% year-over-year to $37.1 million, compared with a TTM value of $37.1 million through Dec 2023, up 20.31%, and an annual FY2023 reading of $37.1 million, up 20.31% over the prior year.
  • Long-Term Deferred Tax was $37.1 million for Q4 2023 at Volitionrx, up from $30.9 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $37.1 million in Q4 2023 and bottomed at $24.4 million in Q4 2020.
  • Average Long-Term Deferred Tax over 4 years is $29.4 million, with a median of $28.1 million recorded in 2021.
  • The sharpest move saw Long-Term Deferred Tax increased 3.56% in 2021, then grew 21.95% in 2022.
  • Year by year, Long-Term Deferred Tax stood at $24.4 million in 2020, then rose by 3.56% to $25.3 million in 2021, then increased by 21.95% to $30.9 million in 2022, then rose by 20.31% to $37.1 million in 2023.
  • Business Quant data shows Long-Term Deferred Tax for VNRX at $37.1 million in Q4 2023, $30.9 million in Q4 2022, and $25.3 million in Q4 2021.